DeepMed Research

St. Jude Children's Research Hospital

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1962-01-01

Employees: -

Market Cap: -

Website: http://www.stjude.org/

Clinical Trials

Large Cell Lymphoma Pilot Study III

Not Applicable

Completed

Conditions: Lymphoma, Large Cell
Lymphoma, Non-Hodgkin

Interventions: Drug: Doxorubicin, Cotrimoxazole, Carboplatin, Ifosfamide, Dexamethasone, Prednisone, Vincristine, Cytarabine, Methotrexate, Etoposide, Cyclophosphamide, Vinblastine
Procedure: Stem cell transplant,
Radiation: Radiation Therapy

First Posted Date: 2005-09-16

Last Posted Date: 2008-05-07

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 8

Registration Number: NCT00187070

Locations: 🇺🇸
St. Jude Children's Reaearch Hospital, Memphis, Tennessee, United States

Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma

Not Applicable

Completed

Conditions: Lymphoblastic Lymphoma

Interventions: Drug: Vincristine
Procedure: Radiation Therapy
Drug: Daunomycin
Drug: L-Asparaginase
Drug: Cytarabine
Drug: Methotrexate
Drug: Mercaptopurine
Drug: Etoposide
Drug: Cyclophosphamide
Drug: Prednisone
Drug: Dexamethasone

First Posted Date: 2005-09-16

Last Posted Date: 2008-04-23

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 42

Registration Number: NCT00187122

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy

Phase 1

Completed

Conditions: Germ Cell Tumors
Hepatic Cancer
Neuroblastoma
Osteosarcoma
Rhabdomyosarcoma

First Posted Date: 2005-09-16

Last Posted Date: 2008-04-10

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 40

Registration Number: NCT00187109

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study

Not Applicable

Completed

Conditions: Osteogenesis Imperfecta

First Posted Date: 2005-09-16

Last Posted Date: 2015-03-04

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 9

Registration Number: NCT00187018

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy Adults

Phase 1

Completed

Conditions: HIV Infections
Human Immunodeficiency Virus

Interventions: Biological: EnvDNA

First Posted Date: 2005-09-16

Last Posted Date: 2017-04-26

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 6

Registration Number: NCT00187148

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers

Phase 1

Suspended

Conditions: Parainfluenza
Respiratory Viral Infections

Interventions: Biological: Sendai virus vaccine

First Posted Date: 2005-09-16

Last Posted Date: 2025-02-19

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 54

Registration Number: NCT00186927

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors

Phase 1

Completed

Conditions: Solid Tumors

Interventions: Drug: Irinotecan, ZD1839, Vincristine, Cefixime, Cefpodoxime.

First Posted Date: 2005-09-16

Last Posted Date: 2017-04-26

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 34

Registration Number: NCT00186979

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration

Phase 3

Terminated

Conditions: Pain
Bone Marrow Disease

Interventions: Drug: Fentanyl
Drug: EMLA
Drug: L.M.X4
Drug: Propofol

First Posted Date: 2005-09-16

Last Posted Date: 2017-04-04

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 168

Registration Number: NCT00187135

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation

Phase 1

Completed

Conditions: Osteodysplasia

Interventions: Biological: Marrow stromal cell infusion

First Posted Date: 2005-09-16

Last Posted Date: 2015-03-04

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 8

Registration Number: NCT00186914

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors

Phase 3

Completed

Conditions: Leukemia, Lymphoblastic, Acute
Osteoporosis

Interventions: Other: Placebo
Drug: Calcium carbonate (Tums), vitamin D

First Posted Date: 2005-09-16

Last Posted Date: 2017-05-10

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 429

Registration Number: NCT00186901

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸
Preventive Medicine, University of Tennessee, Memphis, Tennessee, United States
🇺🇸
Metabolic Bone Center at the University of Tennessee, Memphis, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy